arsenic trioxide has been researched along with Carcinoma, Epidermoid in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 15 (53.57) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Aminishakib, P; Asadi, M; Derakhshan, S; Farzaneh, P; Ganjibakhsh, M; Pirzadeh, F; Rahrotaban, S; Tavakoli Shiraji, S | 1 |
| Gao, L; Liu, KJ; Wang, JZ; Wang, Q; Wang, XY; Xiang, B; Zhang, FY | 1 |
| Li, Z; Long, G; Wei, W; Zhang, H | 1 |
| An, L; Bai, B; Chen, J; Li, X; Yang, X | 1 |
| An, L; Li, X; Yang, X | 1 |
| Furuhashi, A; Hosokawa, Y; Karnan, S; Kazaoka, Y; Konishi, H; Nakaoka, T; Ohmura, Y; Ono, T; Ota, A; Yamada, Y | 1 |
| de Faria, GP; Dos Santos Ferreira, AC; Kwee, JK; Pereira, DL | 1 |
| Boyko-Fabian, M; Budach, V; Distel, L; Niehr, F; Tinhofer, I | 1 |
| Béné, MC; Bonnet, A; Chevallier, P; Garandeau, C; Garnier, A; Guillaume, T; Houreau-Langlard, D; Hourmant, M; Le Gouill, S; Moreau, P; Peterlin, P; Tissot, A; Vantyghem, S | 1 |
| Ho, JC; Lam, SK; Leung, LL; Li, YY; Zheng, CY | 1 |
| Goux, D; Guillamin, M; Hamza-Chaffai, A; Khlifi, R; Sichel, F; Trabelsi, F | 1 |
| Gao, Q; Krebsbach, PH; Kumar, P; Ning, Y; Polverini, PJ; Wang, Z | 1 |
| Lu, DP; Zhang, M; Zhao, XH; Zhu, HJ | 1 |
| An, L; Cheng, B; Gao, B; Liu, X; Yang, X | 1 |
| Bi, X; Gu, J; Guo, Z; Mi, Q; Tang, L; Tao, S; Wang, Y; Wu, J | 1 |
| Su, Y; Sun, Z; Zhang, M; Zhang, X | 1 |
| Guo, LP; Li, LW; Li, XY; Lu, SX; Yu, XY; Zhou, Y | 1 |
| Chen, J; Hu, W; Lanza, GM; Shen, B; Wang, K; Zhang, B; Zhang, L; Zhao, F | 1 |
| Du, CW; Li, DR; Lin, YC; Wu, MY | 1 |
| Guo, J; Zhang, ZY | 1 |
| Huang, HS; Liu, ZM | 1 |
| Chang, WC; Chi, CC; Chuang, CH; Ding, L; Hsu, PY; Huang, HS; Liu, ZM; Wang, SH | 1 |
| Huilgol, NG | 1 |
| An, L; Cheng, B; Han, Z; Liu, S; Yang, X | 1 |
| Li, DR; Lin, W; Lin, YC | 1 |
| Hyun, JM; Jung, CW; Kim, BK; Kim, ES; Lee, YY; Park, WH; Seol, JG | 1 |
| Bai, H; Ding, F; Liu, Z; Ou, Y; Wang, X; Wu, M; Xie, D; Yin, S; Zhou, C | 1 |
| Aoyama, H; Kume, Y; Nagira, T; Tsuda, T; Yamamoto, M | 1 |
2 trial(s) available for arsenic trioxide and Carcinoma, Epidermoid
| Article | Year |
|---|---|
A phase I study to study arsenic trioxide with radiation and hyperthermia in advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hyperthermia, Induced; Male; Middle Aged; Oxides; Radiation-Sensitizing Agents; Treatment Outcome | 2006 |
[Relationship between radiotherapy enhancing effect of arsenic trioxide and the proliferation and apoptosis of related protein in nasopharyngeal carcinoma patients].
Topics: Adult; Aged; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Cell Proliferation; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nasopharyngeal Neoplasms; Oxides; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Radiation-Sensitizing Agents; Young Adult | 2007 |
26 other study(ies) available for arsenic trioxide and Carcinoma, Epidermoid
| Article | Year |
|---|---|
The effect of aflibercept and arsenic trioxide on the proliferation, migration and apoptosis of oral squamous cell carcinoma in vitro.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Endoglin; Humans; Mouth Neoplasms; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor B | 2021 |
Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma.
Topics: Adult; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mouth Neoplasms; NAD; Nicotinamide Phosphoribosyltransferase; Oxides | 2017 |
[Knockdown of SOX9 enhances apoptosis of laryngeal squamous cell carcinoma cells induced by As
Topics: Apoptosis; Arsenic Trioxide; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Knockdown Techniques; Gene Silencing; Humans; Laryngeal Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; SOX9 Transcription Factor; Transfection; Vascular Endothelial Growth Factor A | 2018 |
Silibinin induced the apoptosis of Hep-2 cells via oxidative stress and down-regulating survivin expression.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Down-Regulation; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Laryngeal Neoplasms; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidative Stress; Oxides; Reactive Oxygen Species; RNA, Messenger; Silybin; Silymarin; Survivin | 2013 |
Arsenic trioxide induced endoplasmic reticulum stress in laryngeal squamous cell line Hep-2 cells.
Topics: Activating Transcription Factor 4; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Head and Neck Neoplasms; Heat-Shock Proteins; Humans; Laryngeal Neoplasms; Oxides; Squamous Cell Carcinoma of Head and Neck; Transcription Factor CHOP | 2014 |
Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Humans; Membrane Potential, Mitochondrial; Mouth Neoplasms; Oxides; Reactive Oxygen Species | 2014 |
Autophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Oxides; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2015 |
Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Breaks, Double-Stranded; Drug Resistance, Neoplasm; ErbB Receptors; Head and Neck Neoplasms; Humans; Oxides; Protein Kinase Inhibitors; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Protein p53 | 2014 |
Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Humans; Immunocompromised Host; Kidney Transplantation; Leukemia, Promyelocytic, Acute; Lung Transplantation; Male; Middle Aged; Neoplasms, Second Primary; Oxides; Postoperative Complications; Skin Neoplasms; Tretinoin | 2016 |
Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cysteine Proteinase Inhibitors; Drug Therapy, Combination; Female; Leupeptins; Lung Neoplasms; Mice; Mice, Nude; Oxides; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 1; Xenograft Model Antitumor Assays | 2016 |
Cytotoxicity and genotoxicity effects of arsenic trioxide on SQ20B human laryngeal carcinoma cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Comet Assay; DNA Damage; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Oxides; Squamous Cell Carcinoma of Head and Neck | 2017 |
Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone.
Topics: Animals; Arsenic Trioxide; Arsenicals; Bone and Bones; Bone Resorption; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Mouth Neoplasms; Neoplasm Metastasis; Neovascularization, Pathologic; Osteoblasts; Oxides; Radiation, Ionizing; Treatment Outcome; Tumor Stem Cell Assay; Vascular Endothelial Growth Factor A | 2008 |
[Immunofluorescence examination of CK-13 expression in cell line KB differentiated by all-trans retinoic acid or As2 O3].
Topics: Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Differentiation; Fluorescent Antibody Technique; Humans; KB Cells; Keratin-13; Mouth Neoplasms; Oxides; Tretinoin | 2009 |
Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Glutathione; Humans; Intracellular Space; Laryngeal Neoplasms; Membrane Potential, Mitochondrial; Oxides; Reactive Oxygen Species | 2010 |
Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes.
Topics: Adolescent; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Caspase 3; Cell Cycle; Cell Enlargement; Cell Line; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Keratinocytes; Male; Oxides; Skin Neoplasms | 2010 |
Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Colony-Forming Units Assay; Endothelium, Vascular; Heme Oxygenase-1; Humans; Immunoenzyme Techniques; In Vitro Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Oxides | 2012 |
[Mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) gene expression in esophageal squamous cell carcinoma cell line EC9706].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Esophageal Neoplasms; Exons; Gene Expression Regulation, Neoplastic; Humans; Mutation; Neoplasm Proteins; Oxides; Promoter Regions, Genetic; RNA, Messenger; Tumor Suppressor Proteins | 2011 |
Near infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxide.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Body Weight; Carbocyanines; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Gene Expression; Injections, Intraperitoneal; Injections, Intravenous; Magnetic Resonance Imaging; Mice; Mice, Nude; Mouth Neoplasms; Neoplasms, Experimental; Oxides; Recombinant Fusion Proteins; Spectroscopy, Near-Infrared; Tumor Burden; Tumor Cells, Cultured | 2012 |
[Arsenic trioxide induces differentiation of human nasopharyngeal carcinoma in BALB/C nude mice xenograft model].
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Differentiation; Cell Division; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Oxides; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
[Investigation of apoptosis mechanism of arsenic trioxide on oral squamous cell carcinoma].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Mouth Neoplasms; Oxides; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Binding Sites; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Oxides; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Proto-Oncogene Proteins pp60(c-src); Sp1 Transcription Factor; Transcriptional Activation | 2006 |
Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxides; raf Kinases; ras Proteins; RNA, Small Interfering; Signal Transduction | 2006 |
Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Laryngeal Neoplasms; Microscopy, Fluorescence; Microtubule-Associated Proteins; Neoplasm Proteins; Oxides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survivin; Tumor Cells, Cultured | 2008 |
Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Caspases; Head and Neck Neoplasms; Humans; Membrane Potentials; Mice; Mitochondria; Oxides; Proteins; Tumor Cells, Cultured | 2001 |
Arsenic trioxide (As(2)O(3)) induced apoptosis and its mechanisms in a human esophageal squamous carcinoma cell line.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Adhesion; Cell Division; DNA Fragmentation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Microscopy, Electron; Oxides; Tumor Cells, Cultured | 2002 |
[A case of lung cancer associated with chronic arsenic poisoning caused by neighborhood exposure of As2O3 from Toroku mine].
Topics: Aged; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Chronic Disease; Female; Humans; Lung Neoplasms; Mining; Occupational Diseases; Oxides | 1987 |